What was Alaunos Therapeutics’s price range in the past 12 months?
Alaunos Therapeutics lowest stock price was €0.99 and its highest was €1.01 in the past 12 months.
What is Alaunos Therapeutics’s market cap?
Currently, no data Available
When is Alaunos Therapeutics’s upcoming earnings report date?
Alaunos Therapeutics’s upcoming earnings report date is Mar 05, 2024 which is 24 days ago.
How were Alaunos Therapeutics’s earnings last quarter?
Alaunos Therapeutics released its earnings results on Nov 14, 2023. The company reported -€0.557 earnings per share for the quarter, missing the consensus estimate of -€0.488 by -€0.07.
Alaunos Therapeutics does not currently pay dividends.
What is Alaunos Therapeutics’s EPS estimate?
Alaunos Therapeutics’s EPS estimate is -€0.42.
How many shares outstanding does Alaunos Therapeutics have?
Currently, no data Available
What happened to Alaunos Therapeutics’s price movement after its last earnings report?
Alaunos Therapeutics reported an EPS of -€0.557 in its last earnings report, missing expectations of -€0.488. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Alaunos Therapeutics?
Among the largest hedge funds holding Alaunos Therapeutics’s share is Discovery Capital Management, LLC. It holds Alaunos Therapeutics’s shares valued at 2M.
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
Copying James Shin's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -83.50% per trade.